Cargando…
Development of emodepside as a possible adulticidal treatment for human onchocerciasis—The fruit of a successful industrial–academic collaboration
Current mass drug administration (MDA) programs for the treatment of human river blindness (onchocerciasis) caused by the filarial worm Onchocerca volvulus rely on ivermectin, an anthelmintic originally developed for animal health. These treatments are primarily directed against migrating microfilar...
Autores principales: | Krücken, Jürgen, Holden-Dye, Lindy, Keiser, Jennifer, Prichard, Roger K., Townson, Simon, Makepeace, Benjamin L., Hübner, Marc P., Hahnel, Steffen R., Scandale, Ivan, Harder, Achim, Kulke, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297762/ https://www.ncbi.nlm.nih.gov/pubmed/34293063 http://dx.doi.org/10.1371/journal.ppat.1009682 |
Ejemplares similares
-
Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside
por: Hübner, Marc P., et al.
Publicado: (2021) -
Characterization of the Ca(2+)-Gated and Voltage-Dependent K(+)-Channel Slo-1 of Nematodes and Its Interaction with Emodepside
por: Kulke, Daniel, et al.
Publicado: (2014) -
SLO-1-Channels of Parasitic Nematodes Reconstitute Locomotor Behaviour and Emodepside Sensitivity in Caenorhabditis elegans slo-1 Loss of Function Mutants
por: Welz, Claudia, et al.
Publicado: (2011) -
Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis
por: Bah, Germanus S., et al.
Publicado: (2021) -
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside
por: Assmus, Frauke, et al.
Publicado: (2022)